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Coxiella burnetii is the causative agent of Q fever and an obligate intracellular pathogen
in nature that survives and grows in a parasitophorous vacuole (PV) within eukaryotic
host cells. C. burnetii promotes intracellular survival by subverting apoptotic and
pro-inflammatory signaling pathways that are typically regulated by nuclear transcription
factor-κB (NF-κB). We and others have demonstrated that C. burnetii NMII proteins
inhibit expression of pro-inflammatory cytokines and induce expression of anti-apoptotic
genes during infection. Here, we demonstrate that C. burnetii promotes intracellular
survival by modulating NF-κB subunit p65 (RelA) phosphorylation, and thus activation,
in a Type Four B Secretion System (T4BSS)-dependent manner. Immunoblot analysis
of RelA phosphorylated at serine-536 demonstrated that C. burnetii increases NF-κB
activation via the canonical pathway. However, RelA phosphorylation levels were even
higher in infected cells where bacterial protein or mRNA synthesis was inhibited.
Importantly, we demonstrate that inhibition of RelA phosphorylation impairs PV formation
and C. burnetii growth. We found that a T4BSS-defective mutant (Cb1dotA) elicited
phosphorylated RelA levels similar to those of wild type C. burnetii infection treated
with Chloramphenicol. Moreover, cells infected with Cb∆dotA or wild type C. burnetii
treated with Chloramphenicol showed similar levels of GFP-RelA nuclear localization,
and significantly increased localization compared to wild type C. burnetii infection. These
data indicate that without de novo protein synthesis and a functional T4BSS, C. burnetii
is unable to modulate NF-κB activation, which is crucial for optimal intracellular growth.
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INTRODUCTION
Coxiella burnetii is a Gram-negative intracellular bacterial pathogen and the causative agent of Q
fever in humans (Maurin and Raoult, 1999; Miller et al., 2006). Acute Q fever typically manifests as
a self-limiting flu-like illness, with symptoms ranging from sub-clinical to debilitating, and can be
fatal (Maurin and Raoult, 1999; Miller et al., 2006; Toman et al., 2012). Common chronic sequelae
include endocarditis, hepatitis, and a chronic fatigue syndrome (Maurin and Raoult, 1999; Miller
et al., 2006; Toman et al., 2012). Several recent Q fever outbreaks around the world exhibit the
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organism’s global reach (Karakousis et al., 2006; Enserink, 2010;
Dijkstra et al., 2012; Toman et al., 2012; Wielders et al.,
2015). C. burnetii is environmentally stable, acquired through
aerosolization, has a low infectious dose (Moos and Hackstadt,
1987), and is classified as a category B select agent (Maurin and
Raoult, 1999; McQuiston and Childs, 2002; McQuiston et al.,
2002; Miller et al., 2006; Toman et al., 2012). Upon inhalation,
C. burnetii infects alveolar macrophages and replicates within
a host cell-derived parasitophorous vacuole (PV) that retains
many characteristics of phagolysosomes (Heinzen et al., 1999;
Voth and Heinzen, 2007, 2009; van Schaik et al., 2013). The
C. burnetii infectious cycle is ∼6 days long (Coleman et al.,
2004) and is highlighted by (i) invasion of the host cell by the
environmentally stable Small Cell Variant (SCV) form of the
bacterium, (ii) development of an acidified PV (pH < 5), (iii)
differentiation of C. burnetii SCVs into replicative Large Cell
Variants (LCVs), (iv) PV enlargement and logarithmic pathogen
growth, (v) asynchronous LCV to SCV differentiation beginning
around 6 days post infection (dpi), and (vi) eventual cell exit
(Heinzen et al., 1999; Coleman et al., 2004; Voth and Heinzen,
2007).
Intracellular bacteria including C. burnetii promote infection
by targeting and modulating multiple host cell molecular
processes (Bhavsar et al., 2007; Böhme and Rudel, 2009; Voth
and Heinzen, 2009; Lamkanfi and Dixit, 2010; van Schaik
et al., 2013). Manipulation of host nuclear transcription factor
NF-κB signaling is a common strategy used by microbial
pathogens to thwart host innate and adaptive immune responses
(Bhavsar et al., 2007; Rahman and McFadden, 2011). NF-κB is a
vital regulator of genes involved in pro-inflammatory immune
response, cell proliferation, and apoptosis (Beinke and Ley,
2004; Bonizzi and Karin, 2004; Hoffmann and Baltimore, 2006;
Perkins, 2007; Rahman and McFadden, 2011). During normal
cell function, NF-κB transcription factors—p50 (NF-κB1), p52
(NF-κB2), p65 (RelA), cRel, and RelB remain in the cytoplasm
bound to the IκB inhibitory protein and are activated either
via canonical or non-canonical signaling pathways (Beinke and
Ley, 2004; Bonizzi and Karin, 2004; Hoffmann and Baltimore,
2006; Perkins, 2007; Rahman and McFadden, 2011). In either
case, NF-κB activation and nuclear accumulation leads to
inflammatory and immunomodulatory responses (Beinke and
Ley, 2004; Bonizzi and Karin, 2004; Hoffmann and Baltimore,
2006; Perkins, 2007; Rahman and McFadden, 2011). NF-κB
transcriptional factors regulate expression of hundreds of genes
linked to the innate and adaptive immune response as well as
diverse cellular processes such as proliferation, differentiation,
and death (Beinke and Ley, 2004; Bonizzi and Karin, 2004;
Hoffmann and Baltimore, 2006; Perkins, 2007; Rahman and
McFadden, 2011). C. burnetii affects multiple host cell pathways
regulated by NF-κB (Voth et al., 2007; Mahapatra et al., 2010).
We previously demonstrated that de novo C. burnetii protein
synthesis modulates expression of a subset of NF-κB-regulated
inflammatory cytokine genes (IL8, CCL2, CXCL1, and SPP1)
(Mahapatra et al., 2010). C. burnetii protein(s) actively reduces
the RNA level of these genes relative to those found in cells
containing bacteria transiently inhibited with Chloramphenicol
(Cm) (Mahapatra et al., 2010). Interestingly, even though the host
innate immune system is unable to contain primary C. burnetii
infection, NF-κB-dependent cytokine production is commonly
reported (Raoult and Marrie, 1995; Meghari et al., 2005, 2006,
2008; Soraya Meghari et al., 2006; Benoit et al., 2008). For
example, C. burnetii stimulates an atypical M2 form of activation
(Benoit et al., 2008). M2 cells typically have an IL-12low, IL-
23low, IL-10high phenotype with a variable capacity to produce
inflammatory chemotactic cytokines (Benoit et al., 2008). Other
prominent NF-κB-dependent cytokines induced by C. burnetii
include TNF-α, IL-1β, IFN-γ, RANTES, MCP-1, SCYA3, SCYA4,
and IL-8 (Raoult and Marrie, 1995; Ren et al., 2003; Meghari
et al., 2005, 2006, 2008; Soraya Meghari et al., 2006; Benoit
et al., 2008; Mahapatra et al., 2010; Amara et al., 2012; Schoffelen
et al., 2014; Graham et al., 2016). In addition, C. burnetii
regulates host apoptosis at the transcriptional level by altering
expression of NF-κB-mediated cell survival-related genes (cIAP2
and a1/bfl-1) (Voth et al., 2007). Moreover, avirulent C. burnetii
activates Toll like receptor 2 (TLR-2) that typically signals via
the NF-κB pathway (Zamboni et al., 2004). Therefore, existing
data clearly suggest that NF-κB-dependent host cell processes
are targeted by C. burnetii. However, essentially nothing is
known about how C. burnetii modulates NF-κB signaling or
its importance to the pathogen for intracellular survival and
replication.
Intracellular bacterial pathogens including C. burnetii
manipulate eukaryotic cell functions by secreting bacterial
proteins, or effectors, that interact with host cell factors to
promote intracellular survival (Voth and Heinzen, 2009;
Voth et al., 2009, 2011; Toman et al., 2012; van Schaik et al.,
2013; Newton et al., 2014). C. burnetii produces a T4BSS,
and bacterially-derived virulence determinants are delivered
to the host cytosol via this machinery throughout infection
(Voth and Heinzen, 2009; Chen et al., 2010; Toman et al.,
2012; van Schaik et al., 2013). Employing bioinformatics,
bacterial two-hybrid approaches, yeast screens, and genetic
screens, approximately 120 putative C. burnetii T4BSS effectors
have been identified (Voth et al., 2009; Chen et al., 2010; van
Schaik et al., 2013; Newton et al., 2014). However, it remains
unknown whether the C. burnetii T4BSS modulates NF-κB
signaling. Many immune responses seen in in vitro and in vivo
C. burnetii studies have been attributed to LPS and intrinsic
properties of the bacterium (Honstettre et al., 2004; Zamboni
et al., 2004; Shannon et al., 2005a,b; Andoh et al., 2007; Zhang
et al., 2007; Lu et al., 2008). These approaches have not addressed
the possibility that C. burnetii actively modulates the NF-
κB-mediated immune response at the cellular level using the
T4BSS. We hypothesized that C. burnetii modulates host NF-κB
signaling via the T4BSS to promote intracellular survival. In this
study, we analyzed C. burnetii-mediated temporal modulation
of NF-κB activation/signaling throughout the infectious
cycle. We also identified the NF-κB signaling pathway that is
activated/modulated during C. burnetii infection. In addition, we
analyzed the effect of inhibiting NF-κB activation on C. burnetii
growth and development. Finally, using a T4BSS-defective
mutant and transient inhibition of bacterial protein synthesis, we
investigated whether C. burnetii protein(s) activate NF-κB in a
T4BSS-dependent manner.
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MATERIALS AND METHODS
Growth of C. burnetii, Tissue Culture, and
Infection
C. burnetii Nine mile phase II strain stocks were cultivated
in African green monkey kidney Vero cells (CCL-81; ATCC,
Manassas, VA) and purified as previously described (Morgan
et al., 2010). The C. burnetii T4BSS 1dotA mutant strain
(Beare et al., 2012) and C. burnetii T4BSS 1dotA mutant
complemented strain were generously provided by Dr. Bob
Heinzen (NIAID Rocky Mountain Laboratories, Montana) and
grown as previously described (Beare et al., 2012). Non-adherent
human monocytic leukemia derived THP-1 cells (TIB-202;
ATCC) were grown in 75-cm2 tissue culture flasks in RPMI
1640 medium (Gibco, Carlsbad, CA) supplemented with 1 mM
sodium pyruvate, and 10% fetal bovine serum (FBS) at 37◦C in
5% CO2 (Mahapatra et al., 2010). Hela 229 epithelial cells (CCL-
1.2; ATCC) were grown in RPMI 1640 supplemented with 10%
FBS and gentamicin (Invitrogen) at 37◦C in 5% CO2 and 95%
humidified air. Infections of THP-1 cells with C. burnetii NMII
were initiated in 24-well tissue culture plates at a multiplicity of
infection (MOI) of 25. Bacteria were added to 2 × 106 THP-1
cells per well and incubated at 37◦C for 4 h to allow close host
cell-bacteria contact. Fresh media was then added to each well for
a final concentration of 106 cells/ml. This time point represents T
= 0 for infectious studies.
NF-κB Modulation Assay
To assay C. burnetii modulation of NF-κB activation, uninfected
or C. burnetii-infected THP-1 cells were incubated for 72 hpi.
Cells were then incubated in media with (+) or without (−)
bacteriostatic levels (10µg/ml) of Cm for an additional 24 h
(Mahapatra et al., 2010). Total protein lysates were collected
from cell pellets using laemmli sample buffer (Bio-Rad, Hercules,
CA) containing protease and phosphatase inhibitor cocktails
(Sigma). An NF-κB activation control was generated by treating
uninfected THP-1 cells with 50 ng/ml of recombinant human
TNF-α (R&D systems) for 8 h prior to total cellular protein
collection (Voth et al., 2007). For temporal analysis, protein
lysates from paired infected and uninfected THP-1 cells were
collected at 0, 24, 48, 72, 96, and 120 hpi, with one experimental
set transiently treated with 10µg/ml of Cm for the final 24
h while the other set was mock-treated. Cell culture media
was exchanged daily using centrifugation to harvest the cells
and removal of the spent media followed by suspension of the
cells in fresh media ± Cm. Infected and uninfected cells were
handled identically and a minimum of three experiments (N =
3) were carried out for each time point and condition. Temporal
analysis of infected and uninfected differentiated THP-1 cells
treated with Rifampin to inhibit mRNA synthesis was performed
by treating cells with phorbol 12-myristate 13-acetate (PMA;
200 nM; EMD Biosciences, San Diego, CA) overnight. Cells were
infected with C. burnetii, and Rifampin (10µg/ml) was added
(+Rif) or not (−Rif) at the time of infection. Total protein lysates
were collected at 2, 24, 48, 72, and 96 hpi for immunoblot analysis
as described below.
RelA Inhibition
An inhibitory peptide (IP)—DRQIKIWFQNRRMKWKKNGLL
SGDEDFSS (Novus Biologicals)—that competitively inhibits
phosphorylation of RelA (S529/S536) and a custom synthesized
control peptide (CP)—RMDRKWKQIFQNKIWRKSSDELLN
DFGGD (Thermofisher scientific)—were used to determine if
inhibition of NF-κB activation alters C. burnetii survival/growth
in host cells. Initially, the IP’s ability to suppress NF-κB activation
in uninfected THP-1 cells was determined. Briefly, 150µm IP
or CP was added to 106 THP-1 cells and incubated at 37◦C,
5% CO2 for 4 h. Recombinant human TNF-α (200 ng/ml; R&D
systems) was then added to induce NF-κB activation. Controls
included untreated THP-1 cells, TNF-α only treated cells, IP
only treated cells, and CP only treated cells. After an additional
12 h incubation, cells were pelleted and total protein lysates
collected. After confirmation via immunoblotting that the IP
does inhibit NF-κB activation, it was used to determine the
requirement of NF-κB activation for C. burnetii survival/growth.
Briefly, 106 THP-1 cells treated with either 10µg/ml of Cm
(Sigma), 200 ng/ml of TNF-α (R&D systems), or IP (150µm)
were inoculated with purified C. burnetii NMII at an MOI of 25.
Prior to inoculation, cells were treated with IP for 4 h or TNF-
α for 1 h. To ensure consistent cellular response, fresh TNF-α
was added every 12 h and IP every 24 h, respectively. At 72 hpi,
cells were harvested for (i) total protein lysates, (ii) IFA after
cytospin as previously described (Mahapatra et al., 2010) to detect
PV formation, or (iii) C. burnetii infectious unit enumeration
by sonication lysis of infected cells, serial dilution, and infection
of HeLa cell monolayers followed by Fluorescent Forming Unit
(FFU) calculation as described (Coleman et al., 2004; Omsland
et al., 2009). Briefly, IFA was used to visualize infected cells
using a Nikon Eclipse TE 2000-S fluorescence microscope.
Fifteen randomly chosen fields of view (FOV) visualized at 20x
magnification were counted per well to determine the average
number of PVs per FOV. For FFU/ml determination, the FOV
average times the area FOV/well and inoculum volume (100 ul)
were multiplied by the dilution factor to determine infectious
particles from each sample treatment.
Immunoblot Blot Analysis
Cell lysates were separated by 12% SDS-PAGE and transferred
to a nitrocellulose membrane (Pierce, Rockford, IL). The
membranes were blocked for 1 h at room temperature with 5%
nonfat milk in Tris-buffered saline (150mMNaCl, 100 mM Tris-
HCl, pH 7.6) containing 0.1% Tween-20 (TBST) (Voth et al.,
2007). Following blocking, membranes were incubated overnight
at 4◦C with 5% nonfat milk in TBST having primary antibodies
for the various target proteins (see following). Detection of
NF-κB was performed using a rabbit monoclonal anti-human
primary antibody specific to the phosphorylated Serine 536 form
of RelA (Cell Signaling Technology, Danvers, MA). Activation
of the non-canonical NF-κB pathway was assayed using rabbit
anti-human polyclonal antibody against p100 (the precursor),
and p52 (active form of NF-kappaB2, Cell Signaling Technology,
Danvers, MA). Determination of C. burnetii density within
infected THP-1 cell lysates was performed using rabbit polyclonal
antibody against the C. burnetii 27-kDa outer membrane protein
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Com1 as previously described (Morgan et al., 2010). Mouse
monoclonal antibodies directed against human β-actin (Sigma,
Saint Louis, MO) were employed as a loading control. After
primary antibody incubation, the membranes were washed 3X
with TBST then incubated with either anti-rabbit or anti-mouse
IgG secondary antibody conjugated to horseradish peroxidase
(KPL, Gaithersburg, MD) for 1 h at room temperature, washed
3X in TBST and detected by chemiluminescense following
the manufacturer’s directions (ECL SuperSignal West Pico
Chemiluminescent Substrate, Pierce, Rockford, IL). Visualization
and digital imaging of immunoblots was performed on a
FluorChem HD2 Imaging System (Alpha Innotech Corporation,
Leandro, CA).
Densitometry
The signal density of the detected bands in experimental samples
were analyzed by ImageJ (version 1.46 h) as described previously
(Schneider et al., 2012). Briefly, relative phosphorylated RelA
band intensity was normalized to β-actin and quantified with
respect to uninfected THP-1 cells (Figure 1A) and C. burnetii
infected THP-1 cells at 24 hpi (Figure 2A). To examine the role
of non-canonical NF-κB signaling pathway, relative NF-κB p100
FIGURE 1 | Immunoblot analysis of C. burnetii modulation of NF-κB
activation. (A) Top panel—immunoblot detection of phosphorylated RelA.
Bottom panel—β-actin loading control. Uninfected THP-1 cells without Cm
(U−Cm). Uninfected THP-1 cells with Cm (U+Cm). Infected THP-1 cells
without Cm (I−Cm). Infected THP-1 cells with Cm (I+Cm). All samples were
collected at 72 hpi. TNF-α-treated cells were used as positive controls for RelA
phosphorylation. (B) Graph—difference in RelA protein phosphorylation levels
relative to normalized β-actin. The Y-axis represents fold changes in
phosphorylated RelA and the X axis indicates samples. Results represent the
mean of three independent experiments. Error bars represent ± SD.
Statistically significant differences between U−Cm and I−Cm or I+Cm are
represented as *P ≤ 0.001—(Student’s t-test).
and NF-κB p52 band intensity was normalized to β-actin and
quantified with respect to C. burnetii infected THP-1 cells at 24
hpi (Figure 3). In Figure 4D, relative C. burnetii Com1 band
intensity was normalized to β-actin and quantified with respect to
C. burnetii infected THP-1 cells at 72 hpi. For Figure 5A, relative
phosphorylated RelA band intensity was normalized to β-actin
and quantified with respect to uninfected THP-1 cells.
Immunofluorescent Microscopy
An indirect immunofluorescence assay (IFA) was used to
enumerate PV and infectious C. burnetii. For immuno-staining,
methanol-fixed C. burnetii-infected cells were incubated 1 h with
polyclonal Guinea pig anti-C. burnetii primary sera diluted in
PBS, 2% BSA. After 3 PBS washes, samples were incubated 1 h
with Alexa488-conjugated goat anti-Guinea pig secondary IgG
(Molecular probes, Thermo Fisher) also diluted in PBS, 2% BSA.
DAPI (4’,6-diamidino-2-phenylindole) was used in the secondary
incubation to stain total DNA. Labeled cells were visualized using
a Nikon Eclipse TE 2000-S fluorescence microscope with a Nikon
DS FI1 camera and NIS-ELEMENTS F 3.00 software (Mahapatra
et al., 2010). A minimum of 15 fields per sample were counted
using the 20x objective. All experiments were performed with 3
biological samples and statistical analyses were performed using
a paired Student’s t-test.
Transfections and GFP-RelA/DAPI
Co-Iocalization Assay
Hela cells were transiently transfected with the GFP-RelA
plasmid (Addgene) using X-tremeGENE 9 DNA Transfection
Reagent (Roche Life Sciences), as described by the manufacturer.
Transfected cells were grown overnight and then inoculated
with either C. burnetii NMII, C. burnetii ∆dotA (Beare et al.,
2012), or a C. burnetii dotA-complemented strain (Beare et al.,
2012). Separate cells were also infected with C. burnetii NMII
concurrent with the addition of Cm (Mahapatra et al., 2010).
C. burnetii ∆dotA strain and dotA-complemented strains were
generously provided by Dr. Robert A. Heinzen (Rocky Mountain
Laboratories, NIAID, NIH, Hamilton, MT) (Beare et al., 2012).
All strains were used at an MOI of 25. At 24 and 48 hpi, cells
were methanol-fixed and IFA performed as above using Guinea
pig anti-C. burnetii primary antibody and Alexa555-conjugated
goat anti-Guinea pig secondary IgG (Molecular probes, Thermo
Fisher). DAPI was used to stain total DNA. Subcellular co-
localization of GFP-RelA and DAPI in transfected cells was
visualized as above using a 60x oil objective. A minimum of 100
transfected cells were scored per sample. Data shown are the
means of three independent experiments and statistical analyses
were performed using a paired Student’s t-test.
RESULTS
NF-κB Activation is Modulated by
C. burnetii Proteins during Infection
RelA is one of the most extensively studied NF-κB complex
subunits (Sakurai et al., 2003; Bonizzi and Karin, 2004; Perkins,
2007). Similar to cRel and RelB, it contains a 300-amino acid
region with homology to the Rel proto-oncogene (RH domain)
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4 December 2016 | Volume 6 | Article 188
Mahapatra et al. C. burnetii Modulates Host NF-κB Activation
FIGURE 2 | Temporal analysis of NF-κB activation in C. burnetii-infected THP-1 cells. (A) Representative immunoblots showing NF-κB activation and controls
over a time course of C burnetii infection. Top panel—RelA probed with a monoclonal antibody. Middle panel—phosphorylated RelA probed with a monoclonal
antibody against S536. Bottom panel—β-actin loading control. Time (hpi) at which untreated (I−Cm) and Cm-treated (I+Cm) C. burnetii-infected THP-1 cells were
harvested is indicated above lanes. Arrow indicates lane break. (B) Fold change of phosphorylated RelA vs. time in the presence and absence of Cm. Results of
densitometric analysis are presented as the mean of three experiments. Error bars show ±S.E.M. Statistical differences were calculated using a t-test for paired
samples. *Signifies P < 0.05 of I-Cm samples compared to 24 hpi. **Signifies P < 0.05 between paired (I−Cm to I+Cm) samples at each time point. (C) A
representative immunoblot showing phosphorylated RelA levels in PMA-differentiated THP-1 cells treated or mock-treated with Rifampin 2—96 hpi. Top panel—RelA
control probed with a monoclonal antibody. Middle panel—phosphorylated RelA from infected cells mock-treated with Rifampin (−Rifampin). Bottom
panel—phosphorylated RelA from infected cells treated with Rifampin (+Rifampin). Time (hpi) at which cells were harvested is indicated above each lane.
Un = Uninfected cells.
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FIGURE 3 | Immunoblot analysis of NF-κB p100 and p52 in C. burnetii-infected cells. (A) Representative immunoblots showing NF-κB p100 and p52 in
C. burnetii-infected THP-1 cells either treated with Cm (I+Cm) or left untreated (I−Cm). Blots were probed with a polyclonal rabbit antibody against NF-κB (p100/p52)
of human origin (Top/Middle panels, respectively). Bottom panel—β-actin loading control. CD40-treated THP-1 cells served as a p52 positive control. Sample
conditions and time point are indicated above each lane. Arrows indicate lane breaks. (B) Results of densitometric analysis showing fold changes of NF-κB p100
levels over time of infection with and without Cm after β-actin normalization. Error bars show ±S.E.M of three biological experiments. (C) Fold changes of NFκB p52
levels over time of infection with and without Cm after β-actin normalization. Error bars show ±S.E.M of three biological experiments.
and a transactivation domain (Sakurai et al., 2003; Bonizzi and
Karin, 2004; Perkins, 2007). The RH domain harbors motifs
for nuclear localization and binding to specific DNA sequences,
while the transactivation domain contains phosphorylation sites
that remain bound to the inhibitor IκB while in the cytoplasm
(Sakurai et al., 2003; Bonizzi and Karin, 2004; Perkins, 2007).
Phosphorylation of serine 536 (S536) in the transactivation
domain is required for optimal activation (Sakurai et al., 2003;
Bonizzi and Karin, 2004; Viatour et al., 2005; Perkins, 2007). To
determine if NF-κB is modulated byC. burnetii, NF-κB activation
was assayed in THP-1 cells via detection of RelA phosphorylation
during infection and treatment with Cm (Sakurai et al., 2003).
Figures 1A,B reveal that NF-κB is activated during infection as
evidenced by increased levels of phosphorylated RelA, and that
C. burnetii protein synthesis is required to modulate the level of
activation. Compared to uninfected cells, RelA phosphorylated
protein levels increased ∼10-fold in C. burnetii-infected cells.
However, phosphorylated RelA levels were ∼20-fold higher
in infected cells treated with Cm. These results indicate that
C. burnetii proteins modulate NF-κB signaling during infection.
C. burnetii Modulates NF-κB Activation
Temporally during Infection
To assess the dynamics of NF-κB activation throughout infection,
we examined infected THP-1 cells from 24–144 hpi. Cells
were either mock-treated or transiently treated with Cm. We
hypothesized that NF-κB activation would respond directly to
de novo bacterial protein synthesis depending on the stage of
infection (early [24–48 hpi], mid [48–96 hpi], or late [96–144
hpi]). To test this hypothesis, we first investigated the total
levels of RelA. As shown in Figure 2A, RelA levels at each time
post-infection were consistent throughout infection, indicating
C. burnetii does not modulate the relative expression of RelA.
We next assessed RelA phosphorylation in the presence and
absence of transient Cm treatment. Figures 2A,B show that in
the absence of transient Cm treatment, phosphorylated RelA
levels remain low at 24 hpi (early infection). However, when
compared to 24 hpi, RelA phosphorylation levels significantly
increase at 48 hpi (early to mid-infection) and remain elevated
through 96 hpi (mid infection). Notably, transient application
of Cm at 0, 24, and 48 hpi resulted in even higher levels
of phosphorylated RelA at 24, 48, and 72 hpi, respectively,
suggesting that C. burnetii proteins dampen NF-κB activation
during infection. Interestingly, application of Cm at 72 hpi
did not alter RelA phosphorylation levels at 96 hpi relative to
infected cells in the absence of Cm. During late infection times
(96–144 h), RelA phosphorylation was reduced and de novo
C. burnetii protein synthesis did not alter NF-κB activation.
Combined, these results indicate that infection of THP-1 cells
by C. burnetii involves temporal modulation of NF-κB activation
via RelA phosphorylation. While C. burnetii infection triggers
NF-κB activation, de novo C. burnetii proteins significantly
suppress NF-κB activation during early and middle stages of
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FIGURE 4 | C. burnetii development following NF-κB activation or inhibition. (A) Top panel—immunoblot detection of phosphorylated RelA in THP-1 cells.
Bottom panel—β-actin loading control. Sample treatments (±) are indicated above immunoblot panels and correlate to the lanes below. (B) Inhibition of RelA
phosphorylation in THP-1 cells impairs C. burnetii PV formation. 15 fields of view at 20x magnification (>100 cells/field of view) from three independent samples were
analyzed for PV enumeration. Error bars show ±S.E.M. Statistical differences relative to I−Cm were calculated using a t-test for paired samples (*signifies P < 0.05).
(C) Infectious progeny enumeration in Hela cells from three independent samples as measured by IFA and Fluorescent Forming Units (FFUs). Error bars show ± SEM.
Statistical differences relative to I−Cm were calculated using a t-test for paired samples (*signifies P < 0.05). (D) Representative immunoblot showing Com1 levels in
C. burnetii-infected THP-1 cells either untreated or treated with Cm, TNF-α, or RelA IP and harvested at 72 hpi. Top panel—β-actin control. Bottom panel—Com1
detected with a rabbit polyclonal antibody. (E) Differences in C. burnetii Com1 levels relative to normalized β-actin from three independent samples were analyzed. All
samples were analyzed at 72 hpi. C. burnetii growth was examined in THP-1 cells either untreated (I−Cm), or treated with Cm (I+Cm), TNF-α, or RelA IP. Error bars
represent ± SEM. Statistically significant differences relative to I–Cm are represented as *P ≤ 0.05, (Student’s t-test).
intracellular growth. To confirm these findings, we examined the
effect of treatment with the mRNA synthesis inhibitor rifampin
on temporal NF-κB activation during infection. Additionally, to
determine if these observations were infection model-specific,
we assessed infection of PMA-differentiated THP-1 macrophage-
like cells. Cells were treated with rifampin at the time of
infection, and RelA phosphorylation assessed at 2, 24, 48,
72, and 96 hpi. Figure 2C shows that RelA phosphorylation
levels in differentiated THP-1 cells infected with C. burnetii
increased relative to uninfected cells. Furthermore, inhibition
of bacterial mRNA synthesis resulted in even higher levels
of RelA phosphorylation that were evident through 96 hpi
similar to Figure 2A. These observations support our findings
that indicate C. burnetii proteins temporally modulate NF-κB
activation during infection.
C. burnetii Does Not Modulate NF-κB
Activation via the Non-canonical Pathway
The results above demonstrate the involvement of RelA in NF-κB
activation. NF-κB transcription factors are typically activated by
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either the canonical or non-canonical signaling pathway (Beinke
and Ley, 2004; Bonizzi and Karin, 2004; Park et al., 2005; Viatour
et al., 2005; Perkins, 2007). The canonical pathway transmits
signals via RelA activation, while the non-canonical pathway
functions through NF-κB p52 activation (Beinke and Ley, 2004;
Bonizzi and Karin, 2004; Park et al., 2005; Viatour et al., 2005;
Perkins, 2007). Formation of active p52 occurs via proteolytic
processing of the p100 precursor (Beinke and Ley, 2004; Bonizzi
and Karin, 2004; Park et al., 2005; Viatour et al., 2005; Perkins,
2007). Therefore, to determine if the non-canonical pathway is
activated during C. burnetii infection of THP-1 cells, we used
immunoblot analysis to detect NF-κB p100/p52. Figure 3 clearly
demonstrates that C. burnetii does not modulate host cell NF-κB
p100 and p52 levels over the course of infection (24—144 hpi)
in the presence or absence of bacterial protein synthesis. When
compared to C. burnetii-infected cells at 24 hpi, NF-κB p100
levels remain constant throughout infection, and addition of Cm
does not significantly impact p100 expression (Figure 3B). In
contrast, p52 levels are barely detectable and do not significantly
change in the presence or absence of Cm (Figure 3C). Together,
these data reveal that NF-κB activation in infected THP-1 cells
does not involve non-canonical NF-κB signaling.
Inhibition of NF-κB Activation Impairs
C. burnetii Development
To determine if C. burnetii-mediated NF-κB activation is
essential for intracellular survival and growth, we treated THP-
1 cells with an inhibitory peptide (IP) that competitively
inhibits RelA (S529/S536) phosphorylation to suppress NF-κB
activation. Inhibition of RelA phosphorylation was confirmed by
immunoblotting using TNF-α to trigger RelA phosphorylation
(Figure 4A). Figure 4A demonstrates the effectiveness of TNFα
to induce RelA phosphorylation and the IP’s ability to inhibit
RelA phosphorylation. To measure C. burnetii development
following induction (TNFα) or inhibition (IP) of NF-κB
activation, we analyzed (i), the number of treated THP-1 cells
with PV relative to infected, untreated cells, (ii) the number
of infectious progeny produced in Hela cells by treated THP-
1 cell lysates relative to infected, untreated THP-1 cell lysates,
and (iii) levels of the major outer membrane protein Com1
in treated and untreated THP-1 cells as a measure of C.
burnetii total protein. Figures 4B–D show that PV formation,
infectious progeny, and C. burnetii Com1 levels were reduced
by approximately 20–30% in THP-1 cells pretreated with TNF-
α. Of particular interest, Figure 4B demonstrates that, compared
to C. burnetii infected cells, PV are reduced by approximately
60% in IP-treated cells. Figures 4C–E confirm and support
these observations, demonstrating that the number of infectious
C. burnetii produced (Figure 4C) within IP-treated cells as well
as the amount of Com1 detected in these cells (Figures 4D,E)
was reduced by approximately 60%. Collectively, these results
demonstrate that C. burnetii development is significantly
impaired when NF-κB activation is inhibited. Additionally,
unlike Cm treatment,C. burnetii is able to overcome high levels of
activated NF-κB induced by TNF-α application. However, their
growth is marginally inhibited.
C. burnetii Requires a Functional Dot/Icm
T4BSS to Modulate NF-κB Signaling
Pathogenic microorganisms employ unique strategies to interfere
with NF-κB signaling (Rahman and McFadden, 2011). Bacteria
modulate NF-κB signaling (activation or suppression) depending
on requirements of their intracellular lifestyle and niche (Rahman
andMcFadden, 2011). C. burnetii’s close relative, L. pneumophila,
utilizes over 10 Dot/Icm effectors to induce a biphasic pattern of
NF-κB activation (Rahman andMcFadden, 2011; Shin, 2012). To
determine if the C. burnetii T4BSS plays a role in modulating NF-
κB, we analyzed RelA phosphorylation in THP-1 cells infected
with either wild type C. burnetii (± Cm), a C. burnetii T4BSS
∆dotA mutant, or a dotA-complemented strain. Figures 5A,B
reveal that, compared to cells infected with wild type C. burnetii
(I−Cm), levels of phosphorylated RelA were higher in cells
infected withC. burnetii (I+Cm) or the∆dotAmutant. However,
levels of phosphorylated RelA were similar in cells infected with
either wild type C. burnetii (−Cm) or the ∆dotA complemented
strain. Together, these results suggest that C. burnetii protein
synthesis and a functional T4BSS are required for NF-κB
modulation. To confirm this observation and determine if this
event extends to RelA nuclear translocation, we transiently
transfected Hela cells with GFP-RelA and examined nuclear
translocationwhen infecting cells with either wild typeC. burnetii
(± Cm), the ∆dotA mutant, or the ∆dotA-complemented
strain. Migration of GFP-RelA into the nucleus indicates NF-κB
activation. Using immunofluorescence microscopy we visualized
RelA colocalization with DAPI (DNA stain). Figure S1 and
FIGURE 5 | Continued
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FIGURE 5 | Continued
Figure 5C show that at 24 and 48 hpi, GFP-RelA localized to
the nucleus regardless of the C. burnetii strain used to infect
the cells. However, quantification of the amount of GFP-RelA in
the nucleus of infected cells revealed that wild type C. burnetii
(+Cm) and the ∆dotA mutant had approximately 50% more
cells with nuclear-localized GFP-RelA (Figure 5D). These data
clearly demonstrate that NF-κB activation levels are significantly
higher in infected cells treated with Cm and cells infected with
the ∆dotAmutant, suggesting that T4BSS effectors play a crucial
role in modulating NF-κB signaling.
DISCUSSION
Manipulation of host NF-κB signaling via secreted effector
activity is a strategy used by many microbial pathogens to
thwart innate and adaptive immune responses (Rahman and
McFadden, 2011). NF-κB activation typically induces the
expression of hundreds of genes (Beinke and Ley, 2004; Bonizzi
and Karin, 2004; Park et al., 2005; Viatour et al., 2005; Rahman
and McFadden, 2006, 2011; Perkins, 2007). Genes targeted by
NF-κB include those encoding pro-inflammatory cytokines,
chemokines, and adhesion molecules that regulate recruitment
and trafficking of immune cells to the site of infection (Beinke
and Ley, 2004; Bonizzi and Karin, 2004; Park et al., 2005;
Viatour et al., 2005; Perkins, 2007). NF-κB activation also
induces the transcription of genes such as defensins that have
direct microbicidal activity, and enzymes that generate reactive
intermediates (Beinke and Ley, 2004). NF-κB acts as a major
molecular link between the launch of innate and adaptive
immunity by facilitating T cell activation via induction of MHC
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FIGURE 5 | C. burnetii employs the Dot/Icm T4BSS to modulate NF-κB signaling. (A) Immunoblot analysis of NF-κB activation in THP-1 cells (48 hpi) using
wild type C. burnetii (± Cm), a DotA mutant (∆dotA), and a dotA-complemented strain (∆dotA) Comp. Top panel—detection of RelA. Middle panel—detection of
phosphorylated RelA. Bottom panel—β-actin loading control. TNF-α-treated cells were used as positive RelA phosphorylation controls. (B) Differences in
phosphorylated RelA levels relative to normalized β-actin. The Y-axis represents fold changes in phoshorylated RelA by densitometry and the X axis indicates samples.
Results represent the mean of three independent experiments. Error bars represent ± SEM. For statistically significant differences, *signifies P < 0.05 when samples
are compared to U–Cm, **signifies P < 0.05 when samples are compared between I–Cm to I+Cm or ∆dotA. ***Signifies P < 0.05 when samples are compared
between ∆dotA and ∆dotA Comp—(Student’s t-test). (C) Immunofluorescent image showing localization of GFP-RelA (green). C. burnetii was visualized by Alexa-555
(red), and DNA/Nuclei with Dapi (blue). HeLa cells transiently transfected with GFP-RelA (green) vector were infected with the indicated C. burnetii strains for 48 h.
(A–C) Uninfected cells. (D–G,I–L,N–Q,S–V) Cells infected with the indicated C. burnetii strain in which GFP-RelA and DAPI co-localize. Arrows indicate co-localization.
(H,M,R,W) Merged micrographs representing cells infected with the indicated C. burnetii strain where GFP-RelA did not co-localize with DAPI. Bar, 10 µm. (D)
Quantification of GFP-RelA/DAPI co-localization. A minimum of 100 transiently transfected Hela cells from each of three separate experiments was counted to
determine GFP-RelA/DAPI co-localization. Error bars show ± SD. Statistically significant differences (*P < 0.05, Student’s t-test) are shown when samples are
compared to U–Cm at 48 hpi.
proteins and CD80/86 in antigen-presenting cells (Beinke and
Ley, 2004). B cell differentiation is also usually stimulated by
NF-κB activation (Beinke and Ley, 2004). Additionally, NF-κB
plays a critical role in expression of anti-apoptotic proteins
(e.g., c-IAP-1/2, AI/Bfl-1, Bcl-2, and Bcl-XL) (Beinke and
Ley, 2004; Rahman and McFadden, 2011). Regulation of the
cell-cycle protein cyclin D1, which increases cellular survival
and proliferation, is also dependent on NF-κB activation (Beinke
and Ley, 2004; Rahman and McFadden, 2011). Thus, master
regulators such as NF-κB are prime targets for pathogenic
microorganisms that promote survival by “regulating the
regulator” to meet the requirements of their intracellular life
cycle. In the current study, we demonstrate that C. burnetii
modulates host NF-κB during infection in a T4BSS-dependent
manner.
We discovered that C. burnetii modulates NF-κB activation
through a process that requires de novo bacterial protein and
mRNA synthesis (Figures 1, 2). Our findings clearly indicate that
C. burnetii promotes NF-κB activation via RelA phosphorylation
in a temporal manner, and bacterial protein and mRNA synthesis
inhibitors alter activation. These findings indicate that C. burnetii
maintains a balance between activation and suppression of NF-
κB signaling during infection. Depending on the stage of
infection, bacteria typically either activate or suppress NF-κB
signaling (Rahman andMcFadden, 2011). Studies on C. burnetii’s
close phylogenetic relative reveal that L. pneumophila induces
a biphasic pattern of NF-κB activation in human epithelial
cells (Bartfeld et al., 2009; Rahman and McFadden, 2011; Shin,
2012). Short term activation at early time of infection (<8 hpi)
is followed by decreased activation, which is then followed by
long term induction of NF-κB later in infection (Bartfeld et al.,
2009). Unlike L. pneumophila, our data suggest that C. burnetii
activates NF-κB at a low level for at least the first 5 days of a
∼6 day infection cycle (Figure 2A). Importantly, activation is
suppressed relative to Cm- and rifampin-treated infections,
indicating the response of the host cell is robust NF-κB activation
in the absence of ongoing C. burnetii macromolecular synthesis.
Activation and suppression of NF-κB signaling during early to
mid-infection likely promotes cell survival and prevents a robust
immune response.
NF-κB can be activated by canonical and non-canonical
pathways. Our findings indicate that C. burnetii does not
modulate NF-κB via the non-canonical pathway (Figure 3). This
finding is crucial to narrow C. burnetii modulation of NF-κB
activation to canonical pathwaymolecular components upstream
and downstream of RelA. Canonical NF-κB pathway-associated
molecular components, such as host inducer ligands, receptors,
adaptor molecules, IκB proteins, and kinases, may play a crucial
role in C. burnetii-mediated activation or suppression of NF-κB
signaling and are commonly targeted by intracellular bacterial
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pathogens (Rahman and McFadden, 2011). Examples include
Shigella flexneri and Yersinia spp. that use the type III secretion
system effectors OspG and YopP/J, respectively, to prevent IκB
degradation, maintaining NF-κB inactive in the cytosol (Bhavsar
et al., 2007). Conversely, activation of canonical NF-κB signaling
protects several intracellular pathogens includingMycobacterium
tuberculosis (Dhiman et al., 2007), Bartonella henselae (Kempf
et al., 2005), Chlamydia pneumonia (Wahl et al., 2001), Rickettsia
rickettsii (Clifton et al., 1998), and L. pneumophila (Abu-Zant
et al., 2007) from cell death. Our results clearly indicate that
inhibition of RelA phosphorylation restricts PV formation
and reduces infectious progeny production (Figure 4). It is
tempting to speculate that in the absence of some level of
NF-κB activation, THP-1 cells prevent C. burnetii development
by promoting pro-apoptotic mechanisms. It is likely that NF-
κB-mediated anti-apoptotic genes such as c-iap2 and a1/bfl-1,
which are up-regulated in C. burnetii-infected cells (Voth et al.,
2007), would not be expressed when RelA phosphorylation is
abrogated. Together, these findings suggest that two opposing
effects of NF-κB activation occur in C. burnetii-infected cells:
(1) some level of NF-κB activation is required to suppress
pro-apoptotic pathways, which is beneficial for the pathogen,
while (2) robust NF-κB activation would induce the expression
of pro-inflammatory cytokines, ultimately leading to pathogen
clearance from the host.
Finally, to identify C. burnetii factors that modulate NF-
κB signaling during infection, we investigated whether the
C. burnetii T4BSS was involved. In a series of experiments
(Figures 5A–D and Figures S1A,B) we demonstrate that bacteria
lacking a functional T4BSS do not modulate NF-κB activation
during infection. This suggests that C. burnetii uses T4BSS
effectors to either directly or indirectly modulate host NF-κB
activity. Multiple studies indicate that C. burnetii T4BSS effectors
include proteins with eukaryotic-like domains, including ankyrin
repeat domains, tetratricopeptide repeats, coiled-coil domains,
leucine-rich repeats, GTPase domains, ubiquitination-related
motifs, and multiple kinases and phosphatases (Pan et al.,
2008; Voth et al., 2009; Chen et al., 2010; Toman et al., 2012;
van Schaik et al., 2013). Importantly, a significant number of
C. burnetii T4BSS effectors are translocated into the host cell
cytoplasm when expressed in a surrogate L. pneumophila system
(Pan et al., 2008; Voth et al., 2009; Chen et al., 2010; Toman
et al., 2012; van Schaik et al., 2013). Distinct T4BSS effectors
associate with the PV membrane, microtubules, mitochondria,
and the nucleus (Pan et al., 2008; Voth et al., 2009; Chen
et al., 2010; Toman et al., 2012; Larson et al., 2013, 2015;
Weber et al., 2013; van Schaik et al., 2013; Weber et al.,
2016). However, the specific function of the vast majority of
confirmed and putative C. burnetii T4BSS effectors remains
unknown. Interestingly, C. burnetii’s close phylogenetic relative,
L. pneumophila, regulates host NF-κB activation using more
than 10 Dot/Icm-dependent effectors (Rahman and McFadden,
2011; Shin, 2012). As NF-κB is one of the principal regulators
of the host immune response, identifying and characterizing
C. burnetii T4BSS effectors that modulate this pathway and
thoroughly characterizing the mechanism of NF-κB modulation
will significantly contribute to our understanding of C. burnetii
pathogenic mechanisms.
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Figure S1 | C. burnetii uses Dot/Icm T4BSS to modulate NF-κB signaling.
(A) Immunofluorescent image showing localization of GFP-RelA (green). C. burnetii
was visualized by Alexa-555 (red), and DNA/Nuclei with Dapi (blue). HeLa cells
transiently transfected with GFP-RelA (green) vector were infected with the
indicated C. burnetii strains for 24 h. (A–C) Uninfected cells. (D–G,I–L,N–Q,S–V)
Cells infected with the indicated C. burnetii strain in which GFP-RelA and DAPI
co-localize. Arrows indicate co-localization. (H,M,R,W) Merged micrographs
representing cells infected with the indicated C. burnetii strain where GFP-RelA
did not co-localize with DAPI. Bar, 10 µm. (B) Quantification of GFP-RelA/DAPI
co-localization. A minimum of 100 transiently transfected Hela cells from each of
three separate experiments was counted to determine GFP-RelA/DAPI
co-localization. Error bars show ± SD. Statistically significant differences (∗P <
0.05, Student’s t-test) are shown when samples are compared to U–Cm at 24 hpi.
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